A detailed history of Vela Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Vela Investment Management, LLC holds 13,054 shares of ABBV stock, worth $2.35 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
13,054
Previous 14,097 7.4%
Holding current value
$2.35 Million
Previous $2.42 Million 6.62%
% of portfolio
0.81%
Previous 0.76%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$163.84 - $199.33 $170,885 - $207,901
-1,043 Reduced 7.4%
13,054 $2.58 Million
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $157,885 - $184,375
1,020 Added 7.8%
14,097 $2.42 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $733,573 - $835,839
-4,590 Reduced 25.98%
13,077 $2.38 Million
Q4 2023

Jan 30, 2024

BUY
$137.6 - $154.97 $125,766 - $141,642
914 Added 5.46%
17,667 $2.74 Million
Q3 2023

Nov 07, 2023

BUY
$133.59 - $154.65 $109,810 - $127,122
822 Added 5.16%
16,753 $2.5 Million
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $345,453 - $429,894
-2,607 Reduced 14.06%
15,931 $2.15 Million
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $54,373 - $62,619
376 Added 2.07%
18,538 $2.95 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $96,631 - $110,829
720 Added 4.13%
18,162 $2.44 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $224,182 - $285,009
1,629 Added 10.3%
17,442 $2.67 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $221,726 - $275,100
-1,680 Reduced 9.6%
15,813 $2.56 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $1.88 Million - $2.38 Million
17,493 New
17,493 $2.37 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Vela Investment Management, LLC Portfolio

Follow Vela Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vela Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vela Investment Management, LLC with notifications on news.